| Ytd | -6.21% | |
| 1y | -33.23% |
| Open | 6.30 | Prev Close | 6.43 | Low | 6.10 | High | 6.61 | Mkt Cap | 18.38M |
| Vol | 3.66K | Avg Vol | 6.09K | EPS | -15.73 | P/E | N/A | Forward P/E | -1.59 |
| Beta | 2.08 | Short Ratio | 3.79 | Inst. Own | 21.64% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-12 | 50-d Avg | 7.13 | 200-d Avg | 7.09 | 1yr Est | 9.50 |
Landmark independent study reports significantly improved task performance and satisfaction and lowe
Lifeward Ltd. (NASDAQ:LFWD) ("Lifeward" or the "Company"), a diversified biomedical
Lifeward (NASDAQ:LFWD) reported quarterly losses of $(1.46) per share which missed the analyst conse
The agreement brings together Lifeward’s advanced personal exoskeleton technology and Ottobock Care’
Lifeward Ltd. (NASDAQ:LFWD) ("Lifeward" or the "Company"), a global leader in innova
Lifeward Ltd. (Nasdaq: LFWD) ("Lifeward" or the "Company"), a global leader in innov